Literature DB >> 16330748

Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells.

Tatyana A Souza1, B David Stollar, John L Sullivan, Katherine Luzuriaga, David A Thorley-Lawson.   

Abstract

Epstein-Barr virus (EBV) establishes a lifelong persistent infection within peripheral blood B cells with the surface phenotype of memory cells. To date there is no proof that these cells have the genotype of true germinal-center-derived memory B cells. It is critical to understand the relative contribution of viral mimicry versus antigen signaling to the production of these cells because EBV encodes proteins that can affect the surface phenotype of infected cells and provide both T cell help and B cell receptor signals in the absence of cognate antigen. To address these questions we have developed a technique to identify single EBV-infected cells in the peripheral blood and examine their expressed Ig genes. The genes were all isotype-switched and somatically mutated. Furthermore, the mutations do not cause stop codons and display the pattern expected for antigen-selected memory cells based on their frequency, type, and location within the Ig gene. We conclude that latently infected peripheral blood B cells display the molecular hallmarks of classical antigen-selected memory B cells. Therefore, EBV does not disrupt the normal processing of latently infected cells into memory, and deviations from normal B cell biology are not tolerated in the infected cells. This article provides definitive evidence that EBV in the peripheral blood persists in true memory B cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330748      PMCID: PMC1306799          DOI: 10.1073/pnas.0509311102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  59 in total

1.  Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota.

Authors:  Ahmad Faili; Said Aoufouchi; Eric Flatter; Quentin Guéranger; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Nature       Date:  2002-10-31       Impact factor: 49.962

2.  Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

Authors:  Donna Hochberg; Jaap M Middeldorp; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

3.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

Authors:  Nadia L Bernasconi; Nobuyuki Onai; Antonio Lanzavecchia
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

4.  Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process.

Authors:  Igor B Rogozin; Marilyn Diaz
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

5.  Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

Authors:  Michelle A Swanson-Mungerson; Robert G Caldwell; Rebecca Bultema; Richard Longnecker
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  B cell receptor signal strength determines B cell fate.

Authors:  Stefano Casola; Kevin L Otipoby; Marat Alimzhanov; Sibille Humme; Nathalie Uyttersprot; Jeffery L Kutok; Michael C Carroll; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

7.  EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching.

Authors:  Bing He; Nancy Raab-Traub; Paolo Casali; Andrea Cerutti
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

8.  Age-related accumulation of Ig V(H) gene somatic mutations in peripheral B cells from aged humans.

Authors:  Y Chong; H Ikematsu; K Yamaji; M Nishimura; S Kashiwagi; J Hayashi
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

9.  Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.

Authors:  Kohsuke Imai; Geir Slupphaug; Wen-I Lee; Patrick Revy; Shigeaki Nonoyama; Nadia Catalan; Leman Yel; Monique Forveille; Bodil Kavli; Hans E Krokan; Hans D Ochs; Alain Fischer; Anne Durandy
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

10.  An unappreciated role for RNA surveillance.

Authors:  R Tyler Hillman; Richard E Green; Steven E Brenner
Journal:  Genome Biol       Date:  2004-02-02       Impact factor: 13.583

View more
  52 in total

Review 1.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  A model of host response to a multi-stage pathogen.

Authors:  Edgar Delgado-Eckert; Michael Shapiro
Journal:  J Math Biol       Date:  2010-10-02       Impact factor: 2.259

3.  On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

Authors:  Vey Hadinoto; Michael Shapiro; Thomas C Greenough; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

4.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

5.  Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.

Authors:  Amanda R Robinson; Swee Sen Kwek; Stacy R Hagemeier; Coral K Wille; Shannon C Kenney
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses.

Authors:  Andrea M Siegel; Udaya Shankari Rangaswamy; Ruth J Napier; Samuel H Speck
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

7.  Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number.

Authors:  Jill E Roughan; Charles Torgbor; David A Thorley-Lawson
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

8.  Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.

Authors:  Charles M Chau; Xiao-Yong Zhang; Steven B McMahon; Paul M Lieberman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screening.

Authors:  Ning Li; Scott Thompson; Hualiang Jiang; Paul M Lieberman; Cheng Luo
Journal:  Expert Opin Drug Discov       Date:  2010-12       Impact factor: 6.098

10.  The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1.

Authors:  Ryan M Raver; Amanda R Panfil; Stacy R Hagemeier; Shannon C Kenney
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.